PharmiWeb.com - Global Pharma News & Resources
06-Jun-2019

Eckert & Ziegler will be admitted to SDax

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous

06.06.2019 / 09:07
The issuer is solely responsible for the content of this announcement.


Berlin, 6 June 2019. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to SDax as of 24 June 2019. This decision was announced by the Working Committee for Equity Indices at Deutsche Börse AG, Frankfurt / Main, after yesterday's regular review of the small-cap index. In addition to the high transparency requirements of the Prime Standard, the Eckert & Ziegler shares thereby also fulfill the relevant index size criteria of market capitalization and liquidity.

"We are very delighted to be admitted to SDAX. It is a further confirmation of the successful development of our company in the recent years and the attractiveness of our share. In the future, Eckert & Ziegler will thus gain even more attention. I would like to thank all our employees for this great success", explained Dr. Andreas Eckert, CEO of Eckert & Ziegler AG."

The SDax comprises 70 companies which rank below the companies in the MDax and fulfill the selection criteria defined by Deutsche Börse. These companies must be listed in the Prime Standard segment and must have a minimum free float of ten percent. The stocks that fulfill these requirements are selected for the index on the basis of two size criteria, market capitalization based on free float and trading volume.

About Eckert & Ziegler.
Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine.
Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com



06.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 820445

 
End of News DGAP News Service

Editor Details

Last Updated: 06-Jun-2019